Michael Mullan
From Wikipedia, the free encyclopedia
 |
This article relies on references to primary sources or sources affiliated with the subject, rather than references from independent authors and third-party publications. Please add citations from reliable sources. (June 2007) |
Michael Mullan is a biomedical researcher of the β-amyloid protein and its relation to Alzheimer’s disease. Mike Mullan's Alzheimer research is well known among Biomedical Community. Dr. Mullan's Alzheimer research work [1] resulted in identifying the most widely known Swiss Mutation that is present in familial form. Transgenic Animal for Alzheimer Disease uses Swiss Mutation.
Dr. Mike Mullan [2] is currently the director[3] of the Roskamp Institute in Sarasota, Florida. Under Dr. Mike Mullan's guidelines the institute is carrying out cutting edge research in Alzheimer's, Traumatic Brain Research, Gulf War Illness and other neuropsychiatric disorder.
[edit] References
- ^ "Mullan Alzheimer Research" (html). mullanalzheimer.com. http://www.mullanalzheimer.com. "Director: Michael Mullan, M.D. Ph.D"
- ^ "Dr. Mike Mullan Alzheimer Nature Network Profile" (html). michaelmullan.us. http://network.nature.com/profile/U2A697CC2. "Director: Dr. Mike Mullan"
- ^ "Who We Are: Executive Leadership" (html). roskampinstitute.com. http://www.roskampinstitute.com/about_who.html. "Director: Michael Mullan, M.D. Ph.D"
[edit] External links
- About the Roskamp Institute on the rfdn.org website.
- About the Mullan's Alzheimer Research on the Mullan Alzheimer Research.
